Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000769993-24-000350
Filing Date
2024-11-06
Accepted
2024-11-06 14:29:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 LARIMARTHERAP.txt SC 13G 22022
  Complete submission text file 0000769993-24-000350.txt   23932
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

EIN.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Subject) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88225 | Film No.: 241430276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)